Answer
Aug 08, 2025 - 10:08 AM
CagriSema is typically prescribed for adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related comorbidity, particularly those with type 2 diabetes. This eligibility criterion helps target individuals who are most likely to benefit from the weight management and glycemic control properties of the medication.
